the most common ocular disorders worldwide and are a prominent cause of blindness. 1 This highly heritable trait has been subject to many studies, and the search for genes-in particular for myopia-has been ongoing for several years. 2, 3 Myopia is thought to be caused by a visually evoked retina-to-sclera-signaling cascade. Various genes representing different pathways in myopia development have been discovered. 4, 5 These pathways include neurotransmission, retinoic acid metabolism, extracellular matrix remodeling, and eye development. Still, only a small proportion of the heritability of refractive error has been uncovered. 5 It is known that refractive errors are common in patients with inherited retinal dystrophies (IRD), such as retinitis pigmentosa (RP, in particular in X-linked forms 6 ), congenital stationary night blindness, Stargardt disease, and Best macular dystrophy. [7] [8] [9] IRDs are clinically and genetically heterogeneous, usually causing degeneration of a primary cell type, such as the retinal pigment epithelium (RPE), photoreceptors (cones and rods), or other retinal neurons. 10 According to the location of retinal cell dysfunction, they can be classified into RPE-related macular dystrophies, photoreceptor dystrophies (cone-and rod-dominated dystrophies), and inner retina dystrophies (bipolar cell dysfunctions). Stargardt disease, caused by mutations in the ABCA4 gene, is the most common form of macular dystrophy. 11, 12 Other more rare RPE-related macular dystrophies are Best macular dystrophy and pattern dystrophy. Conedominated dystrophies include achromatopsia, cone dystrophies (CD), and cone-rod dystrophies (CRD). 13 Rod-cone dystrophies (RCD), also known as RP, are the largest subtype of IRD, accounting for w50% of all inherited IRDs. 14 Lastly, congenital stationary night blindness (CSNB) is usually caused by defective retinal signaling from the photoreceptors to the ''ON'' bipolar cells. 15 IRDs may serve as naturally occurring experiments to study the specific cell types and structures involved in the development of myopia. Although several former reports refer to an increased incidence of myopia in patients with inherited retinal dystrophies, most do not include specific quantifiable data, and their spectrum of diseases is limited. 6, 7, 16 Here, we studied a large group of patients with a broad spectrum of inherited IRDs. We investigated frequency and degree of refractive error as a function of affected cell type and causal gene, with the aim to detect bottlenecks for myopia development.
METHODS
SUBJECTS: IRD patients were identified at ophthalmogenetic outpatient clinics of Erasmus Medical Center (n ¼ 265) and the Rotterdam Eye Hospital (n ¼ 37). These 2 ophthalmogenetic centers belong to the Dutch IRD registry, the RD5000 Consortium. 17 The total study population consisted of 302 patients with IRD, and we identified 4 groups of primary affected cell type: RPE-related macular dystrophies (RPE; Stargardt and Best disease and PD; n ¼ 77), cone-dominated dystrophies (CD; achromatopsia, CRD, n ¼ 76), rod-dominated dystrophies (RD; RP and RCD; n ¼ 104), and ON bipolar cell dysfunctions (BPCD; n ¼ 45). To compare the distribution of refractive error to a general population, we used a population-based reference group (n ¼ 5550), a combined dataset from 2940 participants (age 45þ years) from the Rotterdam Study III (RS-III), 18 and 2610 participants (age 18þ years) from the Erasmus Rucphen Family Study (ERF). 19, 20 Data of IRD patients enrolled in the RD5000 database were pseudonymized and personal details were only available at their ophthalmological center, which makes informed consent not obligatory. Nevertheless, we created an informed consent to obtain patient approval for data entry in the RD5000 database. Measurements in the Rotterdam Study and ERF were collected after receiving approval from the Medical Ethics Committee of the Erasmus University Medical Center, and all participants provided written informed consent in accordance with the Declaration of Helsinki.
CLINICAL ASSESSMENT:
We retrieved all clinical data from medical charts. These data included Snellen visual acuity, cycloplegic objective refraction based on autorefraction (retinoscopy was used whenever autorefraction failed) followed by subjective refraction, color vision (Hardy-Rand-Rittler color vision test or Ishihara), visual field tested by Goldmann perimetry, and electroretinographic responses according to ISCEV. 21 All ophthalmic data were reviewed by retinal medical specialists with expertise in ophthalmic genetics (L.I.v.d.B., C.C.W.K.).
For RS-III and ERF (reference group) a similar protocol was used for phenotyping; all subjects underwent an ophthalmologic examination, which included noncycloplegic automated measurement of refractive error (Topcon RM-A2000 autorefractor, Tokyo, Japan), followed by subjective refraction, best-corrected visual acuity, fundus photography, and visual field perimetry (Humphrey Visual Field Analyzer; Zeiss, Oberkochen, Germany). MOLECULAR GENETIC ANALYSIS: In the outpatient clinic, patients with inherited IRDs were offered DNA analysis for diagnostic testing. DNA was isolated from peripheral blood lymphocytes using standard procedures. ABCA4 gene mutations were analyzed in CD and RD patients with microarray screening from Asper Biotech (Tartu, Estonia). Genotyping was performed using the autosomal recessive and autosomal dominant RP chip from Asper Biotech (Tartu, Estonia). In patients with RP and deafness suspected for Usher syndrome an additional USH chip from Asper Biotech was used. All mutations were confirmed with Sanger sequencing. When one mutation was found with the autosomal recessive or Usher chip, the whole gene was sequenced in order to identify a second mutation, if present. X-linked CRD or X-linked RCD probands were screened for mutations in the RPGR gene. Patients clinically diagnosed with CSNB were screened for mutations in the CACNA1F, TRPM1, CABP4, and NYX gene.
STATISTICAL ANALYSIS: Spherical equivalent (SE) was calculated according to the standard formula (SE ¼ sphere þ ½ cylinder), and the mean of both eyes was used for analysis. When data from only 1 eye were available, the SE of this eye was used. We categorized SE into low (SE from À1.5 to À3 diopters [D]), moderate (SE from À3 to À6 D), and high (SE of À6 D or lower) myopia; emmetropia (SE from À1.5 to þ1.5 D); and low (SE from þ1.5 to þ3 D), moderate (SE from þ3 to þ6 D), and high (SE of þ6 D or higher) hyperopia, using previously defined criteria. 22 Analyses were stratified by main affected cell type (RPE, CD, RD, or BPCD) and by causal gene. Causal genes that were found in fewer than 3 patients were pooled into a single group (''other genes''). Logistic regression analyses were used to assess the risk of low, moderate, and high myopia and hyperopia vs emmetropia per disease group, using the RS-III and ERF study as the reference group, and adjusting for age and sex. Subgroup analyses (analysis of variance tests, independent samples t test) were performed to compare mean SE between different causal genes, between subgroups and the reference population, between different ABCA4-related dystrophies (Stargardt, CRD, and RCD), and between RPE-related dystrophies (Stargardt, Best, pattern dystrophy). Since age has an influence on SE, we stratified analysis by age (<25 years; > _25 years) and used the Student t test to compare the mean SE between these age groups. All analyses were performed using SPSS version 20 (SPSS Inc, Chicago, Illinois, USA).
RESULTS

CLINICAL CHARACTERISTICS OF THE STUDY POPULATION
(n ¼ 302) categorized by diagnosis are summarized in Table 1 . Of all patients with RPE-related macular dystrophies (n ¼ 77), most were diagnosed with Stargardt disease (n ¼ 54), 18 with Best disease, and only a small group with pattern dystrophy (n ¼ 5). In the group with CD (n ¼ 76), 15 patients had achromatopsia and 61 patients CRD. The largest group was formed by patients with RD, including 104 RCD patients. With 45 CSNB patients, BPCD formed the smallest group.
A DNA sample was available in 83% of all included patients. In 57% of our study population at least 1 mutation was found. In total, 37% of the cases were genetically solved (autosomal recessive, autosomal dominant, or X-linked inherited) ( Table 1 ). This was defined as the identification of 1 (in autosomal dominant or X-linked disease) or 2 pathogenic mutations (autosomal recessive disease). Figure 1 shows the frequency of mutations found in various genes within the subtypes of inherited retinal diseases. Genes causing the disease in fewer than 3 patients were pooled. All gene-specific data can be found in Table 2 .
The distributions of SE in our patient group and reference group are shown in Figure 2 . In CD (mean SE À3.10 D [SD 4.49]), RD (mean SE À2.27 D [SD 4.65]), and BPCD (mean SE À6.86 D [SD 6.38]) the distribution was skewed toward the left (more myopic) compared to RPE-related macular dystrophies (mean SE À0.10 D [SD 3.09]) and the reference group (mean SE þ0.04 D [SD 2.32]). Figure 3 shows the risks of myopia and hyperopia per disease group, compared to the reference population. Persons with ON bipolar cell dysfunctions had the highest risk of refractive error (odds ratio [OR] high myopia 239.7 and OR mild hyperopia 263.2, both P < .0001), followed by cone-dominated dystrophies (OR high myopia 19.5, P < .0001; and OR high hyperopia 10.7, P ¼ .033), rod-dominated dystrophies (OR high myopia 10.1, P<0.0001; OR high hyperopia 9.7, P ¼ 0.001), and RPE-related dystrophies (OR low myopia 2.7; P ¼ .001; and OR high hyperopia 5.8; P ¼ .025). A subgroup analysis within the RPE-related macular dystrophies showed a significant (P < .0001) difference in mean SE between Stargardt patients (n ¼ 54; mean SE À1.10 D [SD 2.68]) and Best patients (n ¼ 18; mean SE þ2.34 D [SD 2.91]). Table 3 shows the mean SE stratified by age at first visit. Mean age at first visit in our study population (n ¼ 302) was 35 years (SD 18), ranging from 0 to 80 years and differing between subtypes. Only patients with rod-dominated dystrophies were significantly (P ¼ .027) more myopic (mean SE À2.83 D [SD 4.65]) at age >25 years compared to < _25 years (mean SE À0.49 D [SD 4.22]). Figure 4 shows the SE distribution for various genes causing inherited retinal dystrophies, and their location in the retina. Most genes (9 out of 14) coincided with myopia. The ABCA4 gene formed the most common disease-causing gene (n ¼ 62; mean SE À2.02 D [SD 3.71]). Mutations in the ABCA4 did not cause statistically different degrees of myopia depending on the diagnosis, that is, Stargardt disease (SE À1.50 [SD 2.85]) and conerod dystrophy (SE À2.72 [SD 4.11]), P ¼ .493. Patients with mutations in the BEST1 gene (n ¼ 11) had a mean SE of þ1.84 D [SD 2.95], which is significantly higher than the mean SE of the ABCA4 (n ¼ 62; P ¼ .051) or the RPGR gene (n ¼ 6; P ¼ .001). Patients with mutations in the RPGR gene (n ¼ 6) were the most myopic (mean SE À7.63 D [SD 3.31) of all, followed by CACNA1F 
DISCUSSION
WE STUDIED REFRACTIVE ERROR IN 302 PATIENTS WITH IRD
who consecutively entered a national database, and found that genes involved in these diseases often coincide with either myopia or hyperopia. Our results show that in particular BPCD is associated with high myopia and high hyperopia, and CD and RP as a group mostly lead to mild myopia. This suggests that bipolar cells may be important players in myopia development.
Although systematic reports are lacking, occasional case series have reported refractive errors in patients with IRD. Mild refractive errors have been described for Stargardt and Best disease 7, 9 ; more severe refractive errors for CSNB and for RP caused by RPGR and RP1. 6, 16, [23] [24] [25] [26] Our comprehensive analyses show that RPE-related dystrophies such as Stargardt, Best, and pattern dystrophy indeed mostly have mild refractive errors. Photoreceptor disorders have more variability in refractive error but are also mildly myopic on average; CDs have a somewhat higher frequency of moderate myopia than RP. Our study indicates that BPCD predominantly leads to severe refractive errors, and notably, the direction of SE is dependent on the causal gene.
Our study has a unique design in myopia research. We selected patients with a known primary defect in the retina and studied the effect on refractive error. We focused on several affected cell types as well as on causal genes within each cell type. Because myopia develops at childhood and early youth, we stratified for age and found differential effects even in those with a very early onset. Our study is the only systematic investigation on refractive error and IRD to date, and it includes a broad spectrum of diagnoses. In addition, we had access to large population-based studies, which we used as a reference population in the evaluation of risk of refractive error. Our study has drawbacks as well. Although our total sample size was substantial, subgroup analyses were limited by small numbers. The age ranges of the 2 reference populations differed; however, comparison to the single populations did not significantly alter the risk estimates (data not shown). Lastly, our IRD patients lacked data on established risk factors for myopia such as familial occurrence of myopia and educational level, as well as the age of onset of myopia.
A striking finding of our study was that malfunctioning bipolar cell synapses can lead to high myopia. Bipolar cells are known to transmit signals from photoreceptors to amacrine and ganglion cells. 27 They can be divided by ON and OFF subtypes. ON bipolar cells depolarize, whereas OFF bipolar cells hyperpolarize when the retina is stimulated by light. Rod signal transmission primarily occurs through ON bipolar cells, whereas cones connect with both ON and OFF bipolar cells. BPCD are known to affect the ON bipolar cells. Whether a dysfunctional OFF bipolar synapse causes refractive errors is unknown, since gene mutations in these cells are lethal and not a cause of IRD. Therefore, this study can only make conclusions about the role of ON bipolar cells in development of myopia. If we take a closer look at genes causing BPCD, our study shows that mutations in CACNA1F, NYX, and TRPM1 often coincide with high myopia, whereas mutations in CAPB4 coincide with high hyperopia. CACNA1F is a presynaptic Ca channel present in the rod; TRPM1 and NYX are essential components of the postsynaptic glutamate receptor complex at the ON bipolar cell dendrites. 25, 28, 29 CACNA1F and CAPB4 are both involved in the calcium-dependent release of glutamate at the photoreceptor synapse, whereas the latter 2 genes are involved in an intracellular signaling cascade converting the glutamate receptor activation into a voltage response of the ON bipolar cell. 25, 29 CAPB4 is a calcium binding protein located in the presynaptic terminal of cones. 25, [29] [30] [31] Mutation in CABP4 leads to photophobia rather than nyctalopia and is considered a cone synaptic disorder. 32 This suggests that the rod-specific ON bipolar cell routing could lead to myopia, whereas cone-specific ON bipolar cell routing leads to hyperopia.
Genes affecting photoreceptors can cause various refractive errors. Mutations in RPGR, which is located in the connecting cilium and is involved in microtubular transport, cause high myopia, whereas mutations in USH2A, which is located at the apical side of the inner segment and is involved in the maintenance of the photoreceptor, cause only mild myopia. Mutations involved in phototransduction genes do not show consistent associations with refractive errors, although they rarely lead to emmetropia. Thus, the critical site for myopia in photoreceptors appears to be the transport area between the inner and outer segment.
The currently known genes for refractive error show some striking overlap with genes for IRD. 4, 33 Tophits have been found in or near genes involved in the visual cycle and retinoic acid metabolism, that is, common variants in RDH5 (encoding retinol dehydrogenase 5) and RGR (encoding the retinal G protein-coupled receptor). 4, 33 Mutations in RDH5 cause a progressive cone dystrophy 34, 35 and fundus albipunctatus, 26, 36 and mutations in RGR are involved in retinitis pigmentosa. 37, 38 Another interesting genomic locus includes CACNA1D (encoding a voltage-sensitive calcium channel), 33 which shows great similarity with the CACNA1F gene mentioned earlier. Both genes encode an alpha subunit in the L-type calcium channel, localized in the presynaptic ribbon terminals of photoreceptors. Lastly, GRIA4 (encoding the ionotropic AMPA glutamate receptor GluR4) encodes a glutamate-gated ion channel that mediates fast synaptic excitatory neurotransmission, is present in the retina, and is crucial for *, significantly different from the reference population at P value < .05 (independent samples t test). Causal genes that were found in fewer than 3 patients were not included in this figure, but their standard error measurements can be found in Table 2 . Bottom: Localization of retinal dystrophy gene products in the retina. In green: cone-specific genes. In red: rod-specific genes. emmetropization. [39] [40] [41] [42] We speculate that mutations in these IRD genes cause retinal dystrophies, whereas common genetic variants within these genes may be clinically significant as myopia.
In conclusion, we showed that many genes involved in IRD coincide with myopia. Most genes cause a relatively mild myopia, but several genes causing BPCD and RP particularly predispose to high myopia. We determined critical sites for refractive error development: transport between inner and outer segment of the photoreceptor, calcium-dependent glutamate release by photoreceptors, and bipolar neurotransmission and routing. These retinal sites are candidates for more in-depth investigation by future functional studies of myopia.
